Agenda - Update on Ii-Key-SARS-CoV-2 vaccine pr
Post# of 36503
![](/assets/46931549/no_avatar_available_thumb.jpg)
Update on Ii-Key-SARS-CoV-2 vaccine program
-China Licensing & Research Agreement advances with $100,000payment guarantee and $1 million advance on development funding
-Licensing opportunity for COVID-19 therapeutic antibodies
Yesterday some disappointment was expressed regarding the breadth of this agenda. Remember the agenda can be anything a caller wants it to be. Just ask the question, if mgmt. doesn't address your issue.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)